Clinical Trial Update: Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 1/2 results comparing postprandial glucose control among BIOD-531, Humalog Mix 75/25, and Humulin R U-500 in adults wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BIOD 531
• Humalog Mix 75/25 (insulin lispro protamine suspension and insulin lispro)
• Humulin R U-500 (insulin regular (human))

Snippet

Sponsor: Biodel | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED